An MCL1-overexpressing Burkitt lymphoma subline exhibits enhanced survival on exposure to serum deprivation, topoisomerase inhibitors, or staurosporine but remains sensitive to 1-beta-D-arabinofuranosylcytosine. (Q40752485)
Jump to navigation
Jump to search
scientific article published on February 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An MCL1-overexpressing Burkitt lymphoma subline exhibits enhanced survival on exposure to serum deprivation, topoisomerase inhibitors, or staurosporine but remains sensitive to 1-beta-D-arabinofuranosylcytosine. |
scientific article published on February 2002 |
Statements
An MCL1-overexpressing Burkitt lymphoma subline exhibits enhanced survival on exposure to serum deprivation, topoisomerase inhibitors, or staurosporine but remains sensitive to 1-beta-D-arabinofuranosylcytosine (English)
Julie A Vrana
Christine K Bieszczad
Emily S Cleaveland
Yan Ma
Jonathan P Park
Thuluvancheri K Mohandas
1 February 2002